Inherited Retinal Diseases and more | Aspiring Retina Specialist @dukeeyecenter | PhD @moorfields | https://xitter.cf/t.co/10ZO18dbOF

Little Rock, AR
Joined March 2013
After 6 years of med school and 4 years of ophthalmology research, intern year, a PhD, 40+ papers, 400+ citations, 3 countries and 2 continents, it’s real. Let me examine your eyes 👀 #ophthalmology #residency #medtwitter – at Little Rock, AR
10
3
1
107
Michalis Georgiou, MD, PhD retweeted
Ophthalmological manifestations in a cohort of Cowden syndrome patients in a large tertiary healthcare system What this study adds · In a large U.S. tertiary system (Mass General Brigham), the observed CS prevalence was 1.28 per 100,000— somewhat higher than other prior population-based estimates. · Among 77 confirmed CS patients, only 17 (22%) underwent ophthalmologic evaluation, and 4 patients (≈24% of those examined; 5% of the cohort) had ocular findings potentially related to CS. Visual acuity was mostly excellent and stable over a median ophthalmic follow-up of 4.5 years in this cohort · Potential CS-related ocular findings included retinal hamartomas, an eyelid capillary hemangioma, a trichilemmoma, and a stable peripapillary hamartoma-like lesion/old CNVM. Only one patient had complete multimodal retinal imaging (OCT, FA, OCTA), underscoring limited ophthalmic documentation and the need for standardized eye screening in CS. · Three of the four patients with ocular findings carried truncating PTEN variants, hinting at a possible genotype association that warrants larger, prospective studies. · No distinct ocular phenotype emerged from the cohort plus literature synthesis, reinforcing calls for multicentre prospective work to define ocular risk and screening guidelines in CS. #Cowden @HMSeye #retina #PTEN
1
1
8
437
Michalis Georgiou, MD, PhD retweeted
Next-generation phenotyping of inherited retinal diseases: Eye2Gene (AI-driven algorithm). Better-than-expert accuracy for 63 common genetic causes. @ucl @npontikos @GeoMichalis @MaximilianPfau3 @sktywagner @riksag @KonBalaskas #NIH @NatMachIntell: brnw.ch/21wUfkJ
1
14
34
2,505
Excited to see advancements in retinal research for X-linked retinitis pigmentosa. The community urges Johnson & Johnson to seek approval for its XLRP gene therapy, offering hope to patients. fightingblindness.org/news/r… @MichelMichaelid @UCL_Retina
3
5
9
803
Michalis Georgiou, MD, PhD retweeted
Happy #RareDiseaseDay2025! 👁️🧬 Let's make this another unbelievable year of discovery for rare eye diseases! @MariyaMoosajee @MichelMichaelid @cm_stanton @neeru_vallabh @KarkStaphonsen @GeoMichalis @HeonJeon #Ophthalmology #IRD #MedTwitter #ophthalmicgenetics #genetherapy
6
13
616
🗞️🚨I am incredibly grateful and humbled to be a part of this remarkable team @MichelMichaelid @UCL_Retina that delivered such a meaningful project. It has truly been life-changing and has had a positive impact on the children and their families. lnkd.in/dfVn6v8T – at Durham, NC
Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study hubs.li/Q037K8wJ0
2
2
14
1,014
Pleasure to see our PDE6A study feature at @AAOjournal @MichelMichaelid – at Durham, NC
In patients with PDE6A-retinitis pigmentosa, despite the presence of cystoid macular edema, there was relative stability in macular parameters. @GeoMichalis @MichelMichaelid ow.ly/3E9m50Toefe
3
9
1,715
New Publication @ARVOiovs 👁️ We expand on our previous work on CNGA3-Achromatopsia, longitudinally assessing the foveal cone mosaic preservation with adaptive optics. Kudos to Mohamed and the whole team! @UCL_Retina @AOIPLab @MichelMichaelid iovs.arvojournals.org/articl… – at Durham, NC
4
10
825
Michalis Georgiou, MD, PhD retweeted
It is an honor to host Joseph Carroll, PhD, Richard O. Shultz, MD & Ruth Works Professor in Ophthalmology from @MedicalCollege as the Dastgheib Pioneer Award in Ocular Innovation distinguished lecturer.
1
1
1
7
633
New in Ophthalmology Retina, our comprehensive analysis of PDE6A-retinopathy. @MichelMichaelid leading and an amazing team of co-authors. This study details the natural history of PDE6A-retinopathy in one of the largest cohort to date. sciencedirect.com/science/ar… – at Durham, NC
7
1
27
1,412
New @AJOphthalmology 🚨🧬👁️ Peer review data of one of the most promising trials in IRDs. Proud to be among an amazing group of collaborators! @MichelMichaelid @UCLeye @Moorfields Safe and well-tolerated, and showed improvements in efficacy assessments. ajo.com/article/S0002-9394(2… – at London, England
1
15
39
1,983
Case report 🦄. Diagnosed RP in a patient with albinism, now confirmed for PDE6A-RP and TYR-albinism. Age-matched controls included. Out at AJO Case Reports. #RetinitisPigmentosa #Albinism #Genetics 👁️@MichelMichaelid Link: sciencedirect.com/science/ar… – at Little Rock, AR
2
2
1
16
868
Ophthalmology Advocacy Day: Team Arkansas advocating for access to quality eye care, safety, research funding, and a sustainable profession. 👁️ @eyeadvocacy @aao_ophth #myf2024 #Advocacy #EyeCare #ResearchFunding #Arkansas
2
23
766
New Publication Alert! Retinal structure in CSNB is stationary and no specific genotype - structure correlates were identified. VA appears to be relatively stable, with rare instances of progression. @MichelMichaelid @tacguimaraes sciencedirect.com/science/ar… – at Little Rock, AR
4
1
20
1,181
Great pleasure to see our comprehensive review out! @MichelMichaelid – at Little Rock, AR
PRER article from @MichelMichaelid and collaborators who provide expert insight into genetics and imaging of photoreceptor degeneration #RetinaAwarenessMonth #retina #RP @MoorfieldsBRC @UCLeye @Wills_Eye featureshttps://www.sciencedirect.com/science/article/pii/S1350946224000090
2
10
1,038
Michalis Georgiou, MD, PhD retweeted
PRER article from @MichelMichaelid and collaborators who provide expert insight into genetics and imaging of photoreceptor degeneration #RetinaAwarenessMonth #retina #RP @MoorfieldsBRC @UCLeye @Wills_Eye featureshttps://www.sciencedirect.com/science/article/pii/S1350946224000090
5
1
13
2,000
We report the genetic findings, clinical spectrum and natural history of Best vitelliform macular dystrophy (BVMD) in a cohort of 222 children and adults. @MichelMichaelid @Moorfields @UCL_Retina Kudos to Yannik Laich and an amazing group of co-authors! – at Little Rock, AR
Best vitelliform macular dystrophy is a slowly progressive disease and phenotype- genotype correlations can be used for more accurate prognostication and counseling in this phenotypically diverse disorder. ow.ly/RAOk50QxSFA
3
19
2,766
Fresh off the press @AJOphthalmology our comprehensive analysis of PDE6B-retinopathy. @MichelMichaelid , Shaima Hashem and an amazing team of co-authors. This study details the natural history of PDE6B-retinopathy in one of the largest cohort to date. ajo.com/article/S0002-9394(2… – at Little Rock, AR
5
13
1,448
Fresh off the press at @AJOphthalmology our comperative analysis study for cataract surgical outcomes in eye with retinitis pigmentosa. @ShakarchiAhmed @MichelMichaelid *Early Surgery *Safe Surgery *Good Outcomes *More CME and PCO ajo.com/article/S0002-9394(2… – at Little Rock, AR
1
5
17
1,366
New in "Progress in Retina and Eye Research" - a comprehensive review on the incredible work of our IRD community over the past two decades. A milestone mid-career review for @MichelMichaelid (>350 publications) and an early career highlight for me (>70) sciencedirect.com/science/ar… – at Little Rock, AR
1
3
27
2,350
New publication @AAOjournal We analyse @MichelMichaelid @UCL_Retina @Moorfields @UCLeye, the genetic findings, clinical spectrum and natural history of Best vitelliform macular dystrophy (BVMD) in a cohort of 222 children and adults. Report 1: aaojournal.org/article/S0161… – at Little Rock, AR
4
1
23
1,633